PB2257: OUTCOME AND PROGNOSTIC FACTORS OF PEDIATRIC PATIENTS WITH HODGKIN LYMPHOMA: A SINGLE-CENTER EXPERIENCE

por Ali, Nesreen, Mansour, Mohamed, Khalil, Ehab, Ebeid, Emad
Publicado 2023

PB1737: OUTCOME OF ACUTE LYMPHOBLASTIC LEUKEMIA IN INFANTS AT THE NATIONAL CANCER INSTITUTE EGYPT: 10 YEARS’ EXPERIENCE

por Ali, Nesreen, Elbadrawy, Dina, Elashry, Mona, Shalaby, Lobna
Publicado 2023

PB2255: ASSESSMENT OF CHEMOTHERAPY-INDUCED TOXICITY IN CHILDREN WITH HODGKIN LYMPHOMA RECEIVING THE EURONET PROTOCOL

por Bekhit, Hala, Eldeeb, Louay, Moussa, Emad, Youssef, Sarah H, Ali, Nesreen
Publicado 2023

A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia

por ElHarouni, Dina, Yassin, Dina, Ali, Nesreen, Gohar, Seham, Zaky, Iman, Adwan, Hassan, Sidhom, Iman
Publicado 2018

PB2254: TREATMENT OUTCOME AND PROGNOSTIC FACTORS IN CHILDREN AND ADOLESCENTS WITH RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA

por Ali, Nesreen, Moussa, Emad, Rahman, Hany Abdel, Hafez, Hanafy, Zaghloul, Mohamed S, Khorshed, Eman, Elwakeel, Madeha, Mehesen, Maha, Hammad, Mahmoud
Publicado 2023